HealthTech

FuturHealth to Deliver Affordable, FDA-Approved GLP-1s Nationwide

FuturHealth to Deliver Affordable, FDA-Approved GLP-1s Nationwide

As restrictions tighten on compounded semaglutide, FuturHealth now offers name-brand GLP-1s—like Wegovy®— through Novo’s cash-pay program

FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless access to FDA-approved GLP-1 medications – including Wegovy® – at highly affordable, cash-pay prices, delivered directly to their doors. This service is enabled by the proven home delivery capabilities of Alto Pharmacy, a leader in technology-powered pharmacy experiences and part of Fuze Health.

Patients prescribed GLP-1 medications by FuturHealth’s network of licensed providers will receive free, next-day delivery from Alto Pharmacy. Additionally, now through July 31, FuturHealth members can access Novo Nordisk’s limited-time, $299 first-month offer for Wegovy® by visiting FuturHealth and accessing the Wegovy cash-pay program. After the first month, eligible participants can continue to receive the medication for $499 a month. Participants may also choose to pay over time through FuturHealth’s Buy Now, Pay Later program with Affirm.

“Our mission is to make people successful in their health journey by offering a program that ensures our members have the best access to medications, in addition to the tools to make them successful with these medications,” said Luke Mahoney, co-founder and CEO of FuturHealth. “We are delighted to provide our patients with seamless, fast and convenient home delivery.”

The announcement comes as compounded semaglutide faces mounting legal restrictions, making access to name-brand alternatives more important than ever. In addition to medication fulfillment, FuturHealth’s program includes physician-led care, lab work, custom meal plans, and ongoing behavioral support tools, creating a 360-degree experience for lasting results.

For more information about FuturHealth’s innovative approach, and to take FuturHealth’s quiz, visit www.fh.co. For more information about FuturHealth’s consumer direct pricing program, visit landing.fh.co/medication-wegovy.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.

Related posts

Xsolis Ranks for 3rd Consecutive Year on the Inc. 5000

PR Newswire

Aegis Ventures Welcomes Murray Brozinsky for Healthcare Transformation

PR Newswire

Zyter|TruCare Launches Symphony AI to Rewire Workflows

GlobeNewswire